跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 493 条关于
“AmberChrom TQ1”
全部
493
临床试验
265
药物
137
机构
0
资讯
91
去年
DuPont Launches AmberChrom TQ1 Chromatography Resin to Advance Oligonucleotide and Peptide Purification
10天前
Experimental Drug TY1 Reverses Systemic Sclerosis Effects in Preclinical Study
11个月前
Tr1X Receives FDA Clearance for TRX319 CAR-Tr1 Cell Therapy in Progressive Multiple Sclerosis
去年
EsoBiotec's In Vivo BCMA CAR-T Therapy, ESO-T01, Enters Clinical Trials for Multiple Myeloma
去年
Immutep's Efti Shows Promise in Lung and Head & Neck Cancers, Advances Autoimmune Program
2年前
Axsome Therapeutics Reports Strong Q1 2024 Financial Results and Pipeline Advancements
2年前
Agenus Highlights Progress of BOT/BAL Program in Q1 2024, Secures $100 Million Royalty Financing
2年前
Vertex Pharmaceuticals Reports Strong Q1 2024 Performance, Advances Pipeline
2年前
FibroGen Highlights Pamrevlumab's Potential in Pancreatic Cancer and Roxadustat's Growth in Q1 2024 Earnings Call
9个月前
Cedars-Sinai Scientists Develop First-in-Class RNA Drug TY1 to Repair DNA and Regenerate Damaged Heart Tissue
第 1 页,共 10 页
上一页
下一页